Cartesian Therapeutics
RNAC
#8478
Rank
S$0.26 B
Marketcap
S$10.24
Share price
17.56%
Change (1 day)
-68.73%
Change (1 year)

EPS for Cartesian Therapeutics (RNAC)

EPS in 2025 (TTM): S-$3.50

According to Cartesian Therapeutics's latest financial reports the company's current EPS (TTM) is S-$3.47. In 2021 the company made an earnings per share (EPS) of S-$9.33 an increase over its 2020 EPS that were of S-$26.83.

EPS history for Cartesian Therapeutics from 2016 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$3.50
2021S-$9.33-65.22%
2020S-$26.83-43.44%
2019S-$47.44-58.08%
2018S-$113.15-9.35%
2017S-$124.81-29.16%
2016S-$176.19